Skip to main content

Table 4 Number of doses and total quantity of factor concentrates administered

From: Circumcision in hemophilia using low quantity of factor concentrates: experience from Dakar, Senegal

Hemophiliacs severity

Bleeding

Inhibitors

Factors concentrates

Doses

Total

1, severe

Yes

Yes

FEIBA/rFVIIa

3/10

3600 IU/450 μg

2, severe

Yes

Yes

FEIBA/rFVIIa

3/6

10800 IU/810 μg

3, severe

Yes

Yes

FEIBA/rFVIIa

3/5

5280 IU/330 μg

4, severe

Yes

No

Refacto

10

7800 IU

5, severe

No

No

Refacto

5

1050 IU

6, severe

No

No

Refacto

5

900 IU

7, severe

No

No

Refacto

5

1500 IU

8, severe

No

Yes

FEIBA/rFVIIa

3/2

2640 IU/66 μg

9, moderate

Yes

No

Refacto

5

1800 IU

10, moderate

No

No

Refacto

3

810 IU

11, moderate

No

No

Refacto

3

1440 IU

12, moderate

No

No

Refacto

3

1080 IU

13, moderate

No

No

Refacto

3

1170 IU

14, moderate

No

No

Refacto

3

1170 IU

15, moderate

No

No

Refacto

3

1270 IU

16, moderate

No

No

Refacto

3

1170 IU

17, moderate

No

No

Recombinate

3

900 IU

18, mild

No

No

Recombinate

3

1440 IU

19, mild

No

No

Recombinate

3

1170 IU

20, mild

No

No

Recombinate

3

1620 IU

21, mild

No

No

Recombinate

3

1710 IU

22, mild

No

No

Recombinate

3

1890 IU

23, mild

No

No

Recombinate

3

2070 IU

24, mild

No

No

Recombinate

3

2340 IU

25, mild

No

No

Recombinate

3

2340 IU

26, mild

No

No

Recombinate

3

1710 IU